factual
Bundled Rebates Documented in Restasis and Remicade Suits
Lawsuits are exposing real bundled-rebate exclusion: in October 2017 Shire sued Allergan alleging bundled rebates preserved its dominance in the dry-eye drug Restasis such that a competitor could give its drug away free and still not win, and a late-2017 complaint alleged Johnson & Johnson used a bundling scheme on Remicade weeks after a cheaper biosimilar launched to induce hospitals and plans to exclude the lower-priced copy.
factualpending
Speaker
Robin FeldmanEvidence Quote
“according to one Medicare plan administrator, given Allergan's bundling scheme, the new competitor could give its drug away for free--numbers still wouldn't work.”
Created: 6/13/2026, 12:12:41 AM
Your notes
Loading notes...